Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03321786 · ClinicalTrials.gov registry record
Legionnaires' Effect on Smell
A clinical trial of Legionnaires' Disease, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT03321786: Completed study of Legionnaires' Disease, sponsored by University of Pennsylvania.
NCT03321786 is a study of Legionnaires' Disease that has completed, run by University of Pennsylvania. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03321786, a study of Legionnaires' Disease, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether survivors of Legionnaires' disease suffer smell loss. A quantitative olfactory test will be performed by the participants. Such testing will require approximately 20-30 minutes of the participant's time. The participants will take the University of Pennsylvania Smell Identification Test (UPSIT), a scratch-and-sniff test to assess their ability to identify odors in a forced- choice format. Volunteers will also complete a questionnaire asking personal history, demographic questions, and medical history.
Primary Outcome
The number of correct odor identification responses out of 40 from the standardized University of Pennsylvania Smell Identification Test. The total number of correct responses will then be compared to standard norms of correct responses based on demographic information such as age and sex. Comparing the scores to the standard norms collected will indicate whether a volunteer is normosmic, hyposmic, or anosmic.
Conditions Studied
Interventions
- OTHER The University of Pennsylvania Smell Identification Test (UPSIT)
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2024-06-15 |
What the finished NCT03321786 record still lists
NCT03321786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 1 condition, with Legionnaires' Disease appearing as the primary indexed condition, and to 1 intervention - of which The University of Pennsylvania Smell Identification Test (UPSIT) is the first listed.
NCT03321786 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03321786 about?
NCT03321786 is a clinical study titled "Legionnaires' Effect on Smell". The goal of this study is to determine whether survivors of Legionnaires' disease suffer smell loss. A quantitative olfactory test will be performed by the participants. Such testing will require approximately 20-30 minutes of the participant's time. The participants will take the University of Penn...
What is the current status of trial NCT03321786?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-09-06. Estimated completion is 2024-06-15.
What conditions does trial NCT03321786 study?
This clinical trial studies the following conditions: Legionnaires' Disease.
What interventions are being tested in trial NCT03321786?
The interventions under investigation include: The University of Pennsylvania Smell Identification Test (UPSIT) (OTHER).
Who is sponsoring clinical trial NCT03321786?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03321786 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI